EP Patent

EP2252290A1 — Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases

Assigned to Bone Therapeutics SA · Expires 2010-11-24 · 15y expired

What this patent protects

The present invention is related to a intra-articular pharmaceutical composition for use in the treatment and/or the prevention of acute or chronic osteoarticular diseases and acute or chronic osteoarticular symptoms especially osteoarthritis, this composition comprising: possibl…

USPTO Abstract

The present invention is related to a intra-articular pharmaceutical composition for use in the treatment and/or the prevention of acute or chronic osteoarticular diseases and acute or chronic osteoarticular symptoms especially osteoarthritis, this composition comprising: possibly an adequate pharmaceutical carrier or diluent, a glycosaminoglycan, a compound activating the alpha 2 adrenergic receptor, an anti-inflammatory agent and stem cells.

Drugs covered by this patent

Patent Metadata

Patent number
EP2252290A1
Jurisdiction
EP
Classification
Expires
2010-11-24
Drug substance claim
No
Drug product claim
No
Assignee
Bone Therapeutics SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.